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Abstract
Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is characterized by the
formation of multiple fluid-filled cysts that destroy the kidney architecture resulting in end-stage
renal failure. Mutations in genes PKD1 and PKD2 account for nearly all cases of ADPKD. Increased
cell proliferation is one of the key features of the disease. Several studies indicated that polycystin-
1 regulates cellular proliferation through various signaling pathways, but little is known about the
role played by polycystin-2, the product of PKD2. Recently, it was reported that as with polycystin-
1, polycystin-2 can act as a negative regulator of cell growth by modulating the levels of the cyclin-
dependent kinase inhibitor, p21 and the activity of the cyclin-dependent kinase 2, Cdk2.
Methods: Here we utilized different kidney cell-lines expressing wild-type and mutant PKD2 as
well as primary tubular epithelial cells isolated from a PKD transgenic rat to further explore the
contribution of the p21/Cdk2 pathway in ADPKD proliferation.
Results: Surprisingly, over-expression of wild-type PKD2 in renal cell lines failed to inactivate Cdk2
and consequently had no effect on cell proliferation. On the other hand, expression of mutated
PKD2 augmented proliferation only in the primary tubular epithelial cells of a rat model but this was
independent of the STAT-1/p21 pathway. On the contrary, multiple approaches revealed
unequivocally that expression of the cyclin-dependent kinase inhibitor, p57KIP2, is downregulated,
while p21 remains unchanged. This p57 reduction is accompanied by an increase in Cdk2 levels.
Conclusion:  Our results indicate the probable involvement of p57KIP2  on epithelial cell
proliferation in ADPKD implicating a new mechanism for mutant polycystin-2 induced proliferation.
Most importantly, contrary to previous studies, abnormal proliferation in cells expressing mutant
polycystin-2 appears to be independent of STAT-1/p21.
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Background
Autosomal Dominant Polycystic Kidney Disease is the
most common hereditary renal disorder with a prevalence
of at least 1:1000 and accounts for 8%–10% for all end-
stage renal failure [1]. The disease is characterized by the
formation of large fluid-containing renal cysts that grow
over time and destroy the renal parenchyma.
It is believed that cysts originate from tubular epithelial
cells that exhibit increased proliferation and reduced dif-
ferentiation. This may happen after a second somatic hit
occurs that inactivates the PKD1 or the PKD2 allele inher-
ited from the healthy parent [2-4]. Microdissection of
cystic kidneys revealed that cyst growth is due to an
increase in cell number and not to the stretching of the
cyst wall. In addition, tubular epithelial cells cultured
from ADPKD cysts display augmented levels of prolifera-
tion and upregulation of proliferation-associated genes
such as c-Myc, Ki-67 and PCNA [5-8]. The role of polycys-
tin-1 (PC-1), the protein product of PKD1, in the prolifer-
ation of tubular epithelium has been documented.
Polycystin-1 has been implicated in a variety of pathways
tied to proliferation, including G-protein signaling, Wnt
signaling and AP-1. [9-12]. Direct evidence about the
involvement of PC-1 in cell cycle regulation was demon-
strated by the observation that PC-1 overexpression acti-
vates the JAK2/STAT-1 pathway, thereby up regulating
p21waf1 and inducing cell cycle arrest in G0/G1 in a proc-
ess requiring functional polycystin-2 (PC-2). Based on
these results it was postulated that mutations in either
gene could result in deregulated growth [13].
Polycystin-2 has been implicated in cell cycle regulation
mainly through its calcium channel activity and its ability
to activate transcription factor AP-1 [14-16]. However,
there was little direct evidence linking polycystin-2 to cel-
lular proliferation. Recently, PC-2 was directly tied to cell
cycle regulation through direct interaction with Id2, a
member of the helix-loop-helix (HLH) proteins that are
known to regulate cell proliferation and differentiation.
Overexpression of wild-type PC-2 in kidney cell lines
induced cell cycle arrest at G0/G1, through upregulation
of p21 and subsequent inhibition of Cdk2 kinase activity.
This process was dependent on both PC-2-Id2 interaction
and PC-1-dependent phosphorylation of PC-2. Although
inhibition of Id2 expression corrected the hyperprolifera-
tive phenotype of mutant cells, the contribution of p21/
Cdk2 pathway on the abnormal cell proliferation was not
clearly addressed [17]. In an independent study, PC-2 was
shown to regulate proliferation and differentiation of kid-
ney epithelial cells and suggested that its calcium channel
activity may play an important role in this process [18].
In this study, we examined the contribution of the JAK2/
STAT-1/p21/Cdk2 pathway on PC-2-dependent kidney
epithelial cell proliferation. We utilized cell lines HEK293
and NRK-52E expressing wild-type and mutant PC-2 as
well as primary tubular epithelial cells from a PKD2-
mutant transgenic rat [19]. Interestingly, expression of
mutant PC-2 had an effect on the aforementioned path-
way only in the primary epithelial cells expressing mutant
PKD2, but this was independent of p21. On the contrary
multiple approaches provided unequivocal evidence that
a different cyclin-dependent kinase inhibitor, p57, is
reduced in these cells. These results suggest that p57 might
be the end-point of an alternative pathway that regulates
PC-2-induced proliferation in ADPKD.
Methods
Cell culture and isolation of renal primary epithelial cells
Human embryonic kidney 293 cells, PC-2 overexpressing
cells and the rat epithelial cell line NRK-52E were main-
tained in DMEM medium supplemented with 10%
(HEK293) or 5% (NRK-52E) fetal bovine serum (FBS).
Renal primary epithelial cells were isolated from a 7.5
week-old PKD2 mutant trangenic rat (TGR (CMV-hPKD2/
1–703)), abbreviated in the text as: PKD2(1–703) [19].
There were two transgenic rat lines created initially, 111
and 247, expressing a truncated PC-2, owing to a STOP
codon at postion 704. Of the two models 247 was chosen
for further work owing to a more severe phenotype. Line
111 is not maintained at the moment [19]. The primary
cells were isolated by a sequential filtration method as fol-
lows: Normal Spraque-Dawley rats and PKD2(1–703) rats
were sacrificed following standard procedures; kidneys
were extracted and minced under sterile conditions. The
cell mixture was passed through a 180 μm metal sieve
(Retsch, Germany) followed by filtration through a 40 μm
nylon cell strainer (BD Biosciences). The retained cells
were collected and passed through a second 100 μm cell
strainer. The filtrate of this step comprises the tubular epi-
thelial fraction of the kidney homogenate. Tubular epithe-
lial cells were cultured on laminin-coated tissue culture
plates and maintained in Endothelial Cell Growth
Medium (PromoCell, Germany) supplemented with
5%FBS, ECGS, EGF, Hydrocortison, Amphotericin B and
Gentamycin. Under these conditions the cells maintained
their epithelial phenotype for at least 4 passages.
Antibodies
The following antibodies were used in this study: mouse
anti-HA, goat anti-p21, goat anti-Cdk2 (Santa Cruz, Bio-
technology), rabbit-anti phospho STAT1 (Cell Signaling),
rabbit anti-p57 (Santa Cruz). The rabbit polyclonal anti-
PC2 (epitope corresponds to amino acids 679–742 of
PC2) was previously described[20]
Plasmids
HA-PKD2  (WT) was generated by cloning wild-type
human  PKD2  in pcDNA 3 (Invitrogen) plasmid. HA-
PKD2/1–702 contains almost the entire of PKD2 (aa 1–BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
Page 3 of 13
(page number not for citation purposes)
702) and was constructed by the addition of a stop linker
in the PKD2 sequence. Finally, HA-PKD2/R742X contains
amino acids 1–742 of PKD2. Both, HA-PKD2/1–702 and
HA-PKD2/R742X were cloned in pcDNA3 vector.
Transient transfection and Western blot analysis
Plasmids were transfected into HEK293 and NRK-52E
cells using Lipofectamine 2000 (Invitrogen) reagent
according to the manufacture's instructions. Western blot
analysis was performed as mentioned before [21]. Briefly,
cells were lysed in Nonipet P-40 (NP40) buffer (0.1%
NP40, 200 mM NaCl, 50 mM TrisCl (pH 7.4) and pro-
tease inhibitors). After centrifugation at 14,000 rpm for 5
minutes, the supernatants were collected. Total amount of
protein was determined using the BCA kit (Pierce). Equal
amount of protein was denatured by addition of equal
volume of 2 × SDS loading buffer and heating for 30 min
at 50°C. Proteins were separated on an SDS-PAGE gel.
After transfer to a PVDF membrane, Western blots were
developed by ECL following the vendor's protocol (Amer-
sham).
Cdk2 Kinase Assay
Cdk2 assay was performed as previously described [22].
Briefly, 250–500 μg of the total cellular protein was
immunoprecipitated with 1 μg of Cdk2 antibody for 2
hours at 4°C. After extensive washing, the precipitate was
subjected to the kinase assay in the presence of 50 mM
HEPES, 7.5 mM MgCl2, 0.5 mM EDTA, 20 mM β-glycero-
phosphate, 1 mM NaF, 5 mM dithiothreitol, 100 μM ATP
and 10 μCi of [γ-32P] ATP in a total volume of 30 μl. As a
substrate, 2 μg of histone H1 (Calbiochem) were added to
the reaction. The reaction was carried out at 30°C for 30
min. After elution, the supernatant was fractionated by
SDS-PAGE, transferred onto a PVDF membrane and auto-
radiographed.
Electrophysiology
The conventional whole-cell voltage-clamp configuration
was used to measure transmembrane currents in single
cells as described previously [20]. Briefly, patch-clamp
recordings were obtained from single cells at room tem-
perature using a Warner PC-505B amplifier (Warner
Instrument Corp., Hamden, CT) and pClamp 8 software
(Axon Instrument, Foster City, CA). Glass pipettes (plain,
Fisher Scientific, Pittsburgh, PA) with resistances of 5–8
MΩ were prepared with a pipette puller and polisher (PP-
830 and MF-830, respectively, Narishige, Tokyo, Japan).
After the whole-cell configuration was achieved, cell
capacitance and series resistance were compensated
(~70%) before each recording period. From a holding
potential of -60 mV, voltage steps were applied from -100
to 100 mV in 20 mV increments with 200 ms duration at
3 s intervals. Current traces were filtered at 1 kHz and ana-
lyzed off-line with pClamp 8. The pipette solution con-
tained (in mM): 100 K-aspartate, 30 KCl, 0.3 Mg-ATP, 10
HEPES, 10 EGTA, and 0.03 GTP (pH 7.2). The extracellu-
lar solution contained (in mM): 135 NaCl, 5.4 KCl, 0.33
NaH2PO4, 1 MgCl2, 1.8 CaCl2, 5 HEPES, 5.5 glucose (pH
7.4) or 130 KCl, 1 MgCl2, 10 HEPES, 0.1 CaCl2, and 5 glu-
cose (pH 7.4).
Cell Cycle Analysis
Cells were seeded in six-well plates in triplicates. Upon
attachment, cells were synchronized by serum starvation
for 24 h followed by addition of 10% serum-containing
medium for the HEK293 or 2% serum-containing
medium for the primary cells, for 24 hours. Cells were
harvested, fixed with 80% cold ethanol followed by treat-
ment with 25 μg/ml Ribonuclease A (SIGMA) and 50 μg/
ml propidium iodide (SIGMA) for 30 min at 37°C. After
incubation the cells were analyzed by FACS.
Gene Expression Profiling with Microarrays
Gene expression profiles of primary tubular epithelial
cells (TECs) isolated from PKD2(1–703) rats and SD rats
were compared. RNA isolation, cDNA and cRNA synthesis
and hybridization to arrays of type Rae230A from Affyme-
trix (Santa Clara, CA, USA) were performed according to
the recommendations of the manufacturer. Microarray
data was analysed based on a mixed model analysis using
JMP Genomics, version 3.0 (SAS Institute, Cary, NC,
USA). Standard settings were used, except the following
specifications[23]: log-linear mixed models [24], were fit-
ted for values of perfect-matches, with probe and rat
group considered to be constant and the array-id random.
Custom CDF, [25] with Unigene based gene/transcript
definitions different from the original Affymetrix probe
set definitions was used to annotate the arrays. Microarray
data were submitted to NCBI GEO http://
www.ncbi.nlm.nih.gov/geo/query, sample number
[GSE11500].
Quantitative RT-PCR
Total RNA (1 μg) was isolated from cultured cells using
the Rneasy Mini kit (Qiagen) and was reverse transcribed
with the Protoscript reverse transcription kit (New Eng-
land Biolabs) using the VN(dT)23 primer as recommended
by the manufacturer. As a standard for relative RNA quan-
tification (Calibrator), 1 μg of all sample RNAs was
pooled together and reverse transcribed as mentioned
above. Quantitative RT-PCR (qRT-PCR) amplifications
were performed with a LightCycler (Roche Molecular Bio-
chemicals) using the same starting amount and LightCy-
cler® FastStart DNA MasterPLUS SYBR Green I reagents in
a standard volume of 20 μl. Real-time detection of fluori-
metric intensity of SYBR Green I, indicating the amount of
PCR product formed, was measured at the end of each
elongation phase. Fluorescence values measured in the
log-linear phase of amplification were considered usingBMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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the second-derivative-maximum method of the LightCy-
cler Data Analysis software (Roche Molecular Biochemi-
cals). Relative quantification was performed using serial
dilutions of the Calibrator cDNA to provide a standard
curve for each run. For all experiments, the standard curve
had an error of below 5% and extended over the relative
quantities of all individual samples.
Genes whose differential expression was tested by gene-
specific qRT-PCR analysis were rat p57 (forward primer:
TGATGAGCTGGGAGCTGAG and reverse primer:
TGGCGAAGAAGTCAGAGATG) and Cdk2 (forward
primer: TGTGGCGCTTAAGAAAATCC and reverse primer:
CCAGCAGCTTGACGATGTTA). Differences in the quan-
tity of starting material were compensated by normaliza-
tion with the housekeeping genes HPRT (forward primer:
CTCATGGACTGATTATGGACAGGAC and reverse primer:
GCAGGTCAGCAAAGAACTTATAGCC) and GAPDH (for-
ward primer: GTATTGGGCGCCTGGTCACC and reverse
primer: CGCTCCTGGAAGATGGTGATGG). Normalized
fold-changes between mutant and normal samples were
calculated by the REST XL software.
Data Analysis and Statistics
Data are reported as means ± SEM. Comparisons between
multiple groups were performed using single-factor
ANOVA, and secondary comparisons were performed
using the Tukey test. Statistical analysis was performed
using the SPSS statistical software package. For electro-
physiology experiments, statistical analysis was employed
with the SigmaStat (Chicago, IL) software. Data were
reported as means ± SEM. Due to high variability in cells
transfected with wild type PKD2, statistical significance
was determined by the Mann-Whitey Rank Sum test. Dif-
ferences were considered significant at p < 0.05 if not
stated otherwise (patch clamp and gene expression profil-
ing. Gene expression statistical analysis is described
above.
Results
Generation of stable clones expressing wild-type and 
mutant PKD2 in HEK293 cells
To test the role of PKD2 in renal cell proliferation and spe-
cifically on the p21/Cdk2 pathway, we generated a series
of HEK293 cell lines with stable expression of hemagluti-
nin (HA)-tagged wild-type human PKD2 (WT PKD2), HA-
tagged mutant PKD2  (R742X  PKD2) and a selectable
marker (Vector). The R742X PKD2 encodes for a truncated
PC-2 lacking the polycystin-1 (PC-1) interacting region at
the carboxy-terminal of the protein. R742X, is a disease-
causing PC-2 mutant firstly identified in a Greek-Cypriot
family with Polycystic Kidney Disease type 2 [26-28].
Three individual clones were isolated from each transfect-
ant and used for further experimentation. Immunoblot-
ting of whole cell lysates from the selected clones with an
HA antibody, showed good expression of HA-tagged WT
PKD2 and HA-tagged R742X PKD2 (Figure 1A). The same
lysates were immunoblotted with anti-PC-2 antibody to
demonstrate that we indeed have PC-2 overexpression in
these clones. As seen in figure 1A, endogenous PC-2 is
barely detectable by Western blot analysis in vector-only
and R742X PKD2  transfectants. The lower molecular
weight band detected most likely represents a non-specific
band detected with the anti-PC-2 antibody, since it is
detected on vector-only transfectants and untransfected
cells (Figure 1A and data not shown).
Expression of wild-type or mutant PC-2 does not affect pro- liferation or STAT-1/p21/Cdk2 activity in HEK293 cells Figure 1
Expression of wild-type or mutant PC-2 does not 
affect proliferation or STAT-1/p21/Cdk2 activity in 
HEK293 cells. (A) Whole cell lysates containing equal 
amounts of protein from three stable individual clones of 
each transfectant (Vector-only, HA-WT PKD2 and HA-
R742X PKD2) were analyzed by Western blotting for expres-
sion of p21, phosphorylated STAT-1, PCNA, β-tubulin, HA 
and PC-2. (B) Cdk2 immunoprecipitates from two clones of 
each transfectant were subjected into an in vitro Cdk2 kinase 
assay using Histone 1A as substrate. Equal amount of Cdk2 
was confirmed by immunoblotting the precipitates with anti-
Cdk2 antibody. Data are representative of five independent 
experiments.BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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We used these tools to test the effect of wild-type and
mutant PC-2 expression on the JAK2/STAT-1/p21/Cdk2
pathway, as it was previously implicated in its regulation
by showing that overexpression of wild type PKD1 acti-
vates JAK2 kinase, which in turn phosphorylates STAT-1
[13]. Lysates from synchronized clones were immunob-
lotted with an anti-phospho-STAT-1 antibody, which
detects the expression of serine phosphorylated STAT-1,
and an anti-p21 to detect endogenous p21 expression. As
shown in figure 1A, p21 levels and STAT-1 phosphoryla-
tion were unaffected by wild-type or mutant PKD2 expres-
sion. Equal loading was confirmed by re-probing the
same membrane with anti-β-tubulin.
Similarly, endogenous Cdk2 activity was equivalent
among the different clones as judged by the kinase assay
performed on Cdk2 immunoprecipitates from two
selected clones of each transfectant. Western blot analysis
demonstrated that similar amount of Cdk2 was precipi-
tated from each clone (Figure 1B). Cell cycle analysis per-
formed by propidium iodide (PI) staining revealed that
expression of wild-type or mutant PC-2 does not alter the
cell cycle profile of these cells (Figure 2). Furthermore,
proliferating cell nuclear antigen (PCNA) levels were
equal among the different clones (Figure 1A). Collec-
tively, the results suggest that expression of wild-type and
mutant  PKD2  has no effect on the proliferation of
HEK293 cells.
To determine whether mislocalization of exogenous WT
and R742X PC-2 is responsible for their inability to regu-
late cellular proliferation, we compared the sub-cellular
localization of HA-tagged WT or R742X PC-2 with endog-
enous PC-2 by immunofluoresence. Both HA-tagged WT
and R742X PC-2 were detected at the same subcellular
compartments (endoplasmic reticulum and plasma mem-
brane) as the endogenous PC-2 (data not shown).
ER-localized PC-2 is known to function as a Ca2+-acti-
vated intracellular Ca2+  release channel while plasma
membrane-associated PC-2 is believed to function as a
nonselective cation channel [29-31]. Previous work has
demonstrated that PKD2 overexpression augmented the
amplitude of whole cell currents in renal epithelial cells
[20]. To test the effectiveness of the expressed WT PKD2 in
HEK293 cells we performed whole cell current measure-
ments in vector-only, WT PKD2 and R742X PKD2 clones.
Functional expression of transfected wild type PKD2 in
HEK cells has been shown [32]. Figure 3 shows that stable
expression of wild type PKD2 in HEK cells resulted in a
significant increase in the current amplitude of whole cell
inward currents recorded either in normal extracellular
tyrode solution or symmetrical K+ (Figure 3). Outward
currents were larger in WT PKD2 expressing cells com-
pared to untransfected, mock-transfected, or R742X
Cell cycle profile of HEK293 clones is unaffected by expres- sion of wild-type or mutant PC-2 Figure 2
Cell cycle profile of HEK293 clones is unaffected by 
expression of wild-type or mutant PC-2. Three differ-
ent clones of each transfectant were synchronized and sub-
jected to propidium iodide cell cycle analysis by flow 
cytometry. The percentage of cells in each phase of the cell 
cycle was determined. The results are presented as mean of 
triplicate counts for each clone ± SEM. No statistically signifi-
cant difference was detected. Analysis of serum-starved cells 
demonstrated that more than 90% of the live cells were 
arrested at G0/G1 phase confirming successful synchroniza-
tion of the cells cultured (data not shown).BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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PKD2-transfected cells in symmetrical K+. PKD2-mediated
K+ currents were larger compared to Na+/Ca2+ currents as
was expected for PKD2 which shows higher permeability
to K+ compared to Na+ or Ca2+ [16,20]. Overexpression of
R742X PKD2 did not have a significant effect on whole
cell inward or outward currents in HEK293. Collectively,
the electrophysiology data show that transfection of wild
type PKD2 resulted in functional expression in HEK293
cells. However, PKD2 has no effect on the STAT-1/p21/
Cdk2 pathway or on the proliferation status of these cells.
Examination of the effect of wild-type and mutant PKD2 
on the JAK2/STAT-1/p21/Cdk2 pathway in NRK-52E cells
HEK293 cells were generated by transformation of human
embryonic kidney cell cultures with sheared adenovirus 5
DNA [33]. The cell line has an epithelial morphology and
is widely used as a kidney epithelial model. Nevertheless,
there is controversy as to whether these cells are of true
kidney origin, since expression studies have demonstrated
that HEK293 cells have an unexpected relationship with
neurons [34]. For these reasons we decided to perform the
same experiments in a different cell line system more
closely resembling mature kidney epithelial cells, NRK-
52E.
The rat kidney epithelial cell line, NRK-52E was tran-
siently transfected with vector-only (CT), WT PKD2,
R742X PKD2 and 1–702 PKD2 (a PKD2 mutant lacking
the entire carboxy-terminal region of the protein). At 48
hours after transfection, cells were synchronized by serum
starvation. Whole cell lysates were immunoblotted with
anti-p21 and anti-phospho-STAT-1 antibodies. Neither
p21 levels nor STAT-1 phosphorylation is affected by
expression of wild-type or mutant PKD2 (Figure 4A). Sim-
ilarly, the levels of active Cdk2 were comparable among
the four transfectants. In addition to the JAK2/STAT-1/
p21/Cdk2 pathway, the proliferation capacity of NRK-52E
transfected with WT, R742X and 1–702 PKD2 appeared
unaltered compared to vector only transfectants as judged
by PCNA Western blot analysis. Good expression of the
wild-type PC-2 and of the two truncated proteins was
achieved as judged by anti-HA and anti-PC2 blotting. In
summary, these results duplicate the observation in
HEK293 that wild-type or mutant PKD2 expression do not
Functional expression of PKD2 in HEK293 cells Figure 3
Functional expression of PKD2 in HEK293 cells. Whole cell step currents in vector-only (A and F), wild type PKD2- (B 
and G), or PKD2(742X)-stably transfected HEK293 cells (C and H) in normal extracellular tyrode solution (130K+:135Na+/2 
Ca2+/5.4 K+) (A-C) or symmetrical K+ (130K+:130K+) (F-H). Current-voltage (I–V) curves derived from a step protocol in 
untransfected (black squares), mock-transfected (vector control) (black circles), WT PKD2- (red circles), or PKD2 (R742X)-
stably transfected HEK293 cells (green circles) in normal extracellular tyrode solution (D) or symmetrical K+ (I). ''*'': p < 0.05.BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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modify the activity of the JAK2/STAT-1/p21/Cdk2 path-
way.
Renal tubular epithelial cells from PKD2(1–703) transgenic 
rat display augmented proliferation independent of the 
JAK2/STAT-1/p21/Cdk2 pathway
The unexpected but significant results above, prompted us
to utilize primary renal epithelial cells obtained from a 7.5
week-old mutant PKD2 transgenic rat (1–703) [abbrevi-
ated PKD2(1–703)], expressing a truncated form of PC-2
lacking the C-terminal region of the protein. The trans-
genic animals manifest a cystic phenotype characterized
by the formation of multiple cysts in the kidneys [19].
Tubular renal epithelial cells were isolated by sequential
filtration of renal cells and cultured in low serum-contain-
ing medium. The epithelial character of the isolated cells
and the absence of contaminating fibroblasts were con-
firmed by cadherin and vimentin expression respectively
(Figure 5A).
In contrast to the cell lines examined, primary tubular epi-
thelial cells (TECs) isolated from PKD2(1–703) transgenic
rat, demonstrated an increase in cellular proliferation
compared with their normal counterparts. Specifically,
Western blot analysis on whole cell lysates demonstrated
that TECs isolated from the PKD2(1–703) rat have signif-
icantly higher levels of PCNA than TECs isolated from
normal Sprague-Dawley rats (Figure 5A). In addition, the
percentage of cells in the G0/G1 phase of the cell cycle was
lower in the mutant cells than in normal cells as judged by
cell cycle analysis (90.6 ± 0.93 to 84.1 ± 1.28). In concert,
the percentage of G2/M-phase mutant cells was higher
than G2/M-phase normal cells (5.06 ± 0.31 to 12.9 ±
1.37) (Figure 5B). Despite the higher proliferative activity
of mutant cells, p21 levels and STAT-1 phosphorylation
remain unaltered (Figure 5A), suggesting that PKD2-
induced proliferation is STAT-1/p21-independent.
We then hypothesized that alternative pathways might be
responsible for PKD2-induced proliferation in this sys-
tem. To this end, we performed a genome-wide gene
expression analysis on TECs isolated from two normal
Sprague Dawley rats and three PKD2 (1–703) rats. Differ-
entially expressed genes were identified with ANOVA. We
concentrated only on genes involved in the cell cycle reg-
ulation (Figure 6A). From all the cell cycle genes listed in
figure 6A, only two differ significantly in expression
between normal and mutant cells, those being Cdk2 and
cyclin-dependent kinase inhibitor 1C or p57KIP2. On the
contrary, p21 did not show any significant difference,
confirming the Western blot results (Figure 6A and 5A).
The chip data were verified by quantitative real-time PCR
analysis after normalization using two housekeeping
genes, HPRT and GAPDH. In agreement with the chip
Figure 4
Expression of wild-type or mutant PC-2 does not 
affect proliferation or STAT-1/p21/Cdk2 activity in 
NRK-52E cells. (A). Whole cell lysates containing equal 
amounts of protein from NRK-52E cells trasnsiently trans-
fected with vector-only, HA-WT PKD2, HA-R742X PKD2 
and HA-1–702 PKD2 were analyzed by Western blotting for 
expression of p21, phosphorylated STAT-1, PCNA, tubulin, 
HA and PC-2. A non-specific band is detected in vector-only 
and WT PKD2 lanes in the HA blot and co-migrates with 
mutated PC-2 in this cell line. (B) Cdk2 immunoprecipitates 
from each transfectant were subjected into an in vitro Cdk2 
kinase assay using Histone 1A as substrate. Equal amount of 
Cdk2 was confirmed by immunoblotting the precipitates with 
anti-Cdk2 antibody. Data are representative of three inde-
pendent experiments performed. No statistically significant 
difference was detected.BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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data, p57 mRNA levels were downregulated in the mutant
animals as compared with their normal counterparts
(normalized fold change 4.7 ± 0.19). Similarly, Cdk2
mRNA levels were augmented in the mutant cells (nor-
malized fold change 1.2 ± 0.015) (Figure 7A). Cdk2 pro-
tein upregulation and p57 protein downregulation were
also verified by immunoblotting. Consistent with the
microarray data, Cdk2 protein levels were significantly
elevated in mutant primary cultures (normalized fold
change 2.2 ± 0.06). Similarly, p57 levels were downregu-
lated in mutant TECs (normalized fold change 1.9 ± 0.2)
(Figure 7B). On the contrary, Western blot analysis dem-
onstrated, as expected, that p57 protein levels remain
unchanged in HEK293 stable clones and NRK-52E trans-
fectants (Figure 7C). It should be noted that p57 levels in
the cell lines examined is expressed at very low levels and
it was barely detectable by Western blot. Given that in the
PKD2(1–703) transgenic rat the cysts originate predomi-
nantly from the proximal tubule segment of the nephron,
we wanted to exclude the possibility that proximal tubule
cells are overrepresented in the primary mutant TECs cul-
ture, thus confounding the interpretation of the results. In
order to do that, lysates from normal and mutant TECs
were immunobloted with anti-Megalin antibody, a proxi-
mal tubule marker [35]. As shown on figure 5A, Megalin
protein levels were equivalent among normal and mutant
TECs suggesting that the proportion of cells of proximal
origin was comparable among the different cultures and
did not create a sampling bias.
Discussion
Various studies on renal cystic tissues and cell lines dem-
onstrated that altered regulation of tubular epithelial cell
proliferation is a key factor in the pathogenesis of ADPKD.
What remains unclear is the timing of the misregulated
growth as well as the pathways involved. Recently, in an
attempt to answer these questions a number of groups
provided evidence for the involvement of Cdk2 in the
process of cystogenesis. Progression through the cell cycle
is regulated by a family of cyclin-dependent kinases (CKs)
whose activities are controlled by the relative ratio of cyc-
lins and Cdk inhibitors (CKIs) [36,37]. There are two
classes of CKIs in mammals, the p21CIP1 and p16INK4 fam-
ilies. Members of the p16NK4 family bind and inhibit only
Cdk4 and Cdk6 kinases [38]. In contrast, members of the
p21CIP1 family (p21CIP1, p27KIP1 and p57KIP2) inhibit all
G1/S phase CDKs. The transition of cells from the G0/G1
into the S phase of the cell cycle involves the activities of
Cdk2, Cdk4 and Cdk6 [37].
Bhunia et. al. were the first to address the role of CDKs in
PKD-induced proliferation. Specifically, they demon-
strated that one of the functions of the polycystin-1/2
complex is to regulate the JAK/STAT pathway and conse-
quently control cellular proliferation. They showed that
overexpression of wild-type polycystin-1 can activate
JAK2/STAT-1, a process that resulted in upregulation of
the CKI p21waf1. As expected, increase in p21 levels led to
Primary tubular epithelial cells (TECs) isolated from the kid- neys of a PKD transgenic rat expressing a truncated PC-2  (PKD2(1–703)) display higher proliferative activity compared  with TECs isolated from normal Sprague-Dawley rats Figure 5
Primary tubular epithelial cells (TECs) isolated from 
the kidneys of a PKD transgenic rat expressing a 
truncated PC-2 (PKD2(1–703)) display higher prolif-
erative activity compared with TECs isolated from 
normal Sprague-Dawley rats. (A). Whole cell lysates 
containing equal amounts of protein from TECs isolated from 
normal Sprague-Dawley rat (SD) and TECs isolated from 
PKD transgenic rat (Mut) were analyzed by Western blotting 
for expression of p21, phosphorylated STAT-1, PCNA, tubu-
lin, PC-2, cadherin, vimentin and megalin. All blots are repre-
sentative of experiments performed on at least two different 
transgenic animals. Endogenous PC-2 can be seen on long 
exposures that also bring out high background (not shown) 
(B). Cell cycle profile of normal (SD) or mutants (Mut) TECs. 
The results are presented as mean of triplicate counts (three 
independent cultures) for each animal. ± SEM (ANOVA p < 
0.01. * = significant difference). The data are representative 
of two experiments performed using two different pairs of 
animals.BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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inhibition of Cdk2 and cell cycle arrest. The ability of
polycystin-1 to modulate Cdk2 activity was dependent on
polycystin-2. These results implied that compromised
polycystin-1 activity is expected to have the opposite
effect, thus explaining the abnormal proliferation
observed in ADPKD cystic cells.
An independent study addressed directly the role of PC2
in cell cycle regulation and Cdk2 activity. It was demon-
strated that PC2 could directly interact with Id2, a mem-
ber of the HLH family that is known to control cell
proliferation and differentiation. The direct association of
PC2 with Id2 was shown to regulate the nuclear transloca-
tion of Id2 and thus modulate the cell cycle through the
Genome-wide expression analysis reveals differential expres- sion of Cdk2 and p57 in TECs isolated from transgenic rat  (PKD2(1–703)) Figure 6
Genome-wide expression analysis reveals differential 
expression of Cdk2 and p57 in TECs isolated from 
transgenic rat (PKD2(1–703)). (A). List of cell cycle-
related genes examined by microarray analysis. The (*) 
denotes statistical significance after Bonferroni correction. 
(B). Each data point on the volcano plot stands for one gene. 
The cutoff of p-value after Bonferroni correction is shown by 
the red line. Only the two significantly differentially 
expressed genes are labeled with their gene symbol.
Tubular epithelial cells (TECs) isolated from the PKD2(1– 703) rat (Mut) have reduced p57 and augmented Cdk2  mRNA and protein compared with TECs isolated from nor- mal rat (SD) Figure 7
Tubular epithelial cells (TECs) isolated from the 
PKD2(1–703) rat (Mut) have reduced p57 and aug-
mented Cdk2 mRNA and protein compared with 
TECs isolated from normal rat (SD). (A). Real-time 
PCR of p57 and Cdk2 in isolated TECs. Data represent the 
mean of normalized fold change from three independent 
samples ± SEM (ANOVA p < 0.01. * = significant difference). 
Data were normalized using two housekeeping genes, HPRT 
and GAPDH. (B). Protein levels of p57 and Cdk2 repre-
sented as the mean of normalized fold change of two inde-
pendent Western blot experiments ± SEM (ANOVA p < 
0.05. * = significant difference). Data were normalized by β-
tubulin expression. (C). p57 protein levels were determined 
by western blot analysis in HEK293 stable clones and in 
NRK-52E transfectants. As expected, protein level of p57 is 
not perceptibly altered.BMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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Id2/p21/Cdk2 pathway [17]. Based on these results a
model was proposed according to which PC1 can increase
PC2 phosphorylation leading to enhanced Id2/PC2 inter-
action and reduced Id2 nuclear import. This in turn, pre-
vents Id2 repression of E-box-dependent activation of
transcription of genes such as p21. Increased p21 will
inhibit Cdk2 activity and arrest the cells at G0/G1 phase
of the cell cycle. At the same time PC1 can lead to Cdk2
inhibition independent of Id2 through the JAK/STAT
pathway. Based on this model mutations in either PC1 or
PC2 can disrupt these pathways leading to abnormal cell
proliferation [17]. A recent report also demonstrated
reduced levels of p21 in human and animal PKD tissues
as well as in affected cell lines implying a role of p21/
Cdk2 in cystogenesis [39].
In this study we attempted to examine further this hypoth-
esis. We generated stable clones expressing either wild-
type or mutant R742X PKD2 in HEK293. To our surprise,
overexpression of wild-type PC2 did not affect prolifera-
tion of these cells. Cell cycle profile analysis, PCNA, p21
expression levels and Cdk2 activity remained unchanged
among different transfectants. The reason for this discrep-
ancy remains unclear given that the same cell line and
similar experimental conditions were used in the previous
studies [13,17]. In order to eliminate the possibility that
the exogenously expressed wild-type PKD2 was not func-
tional, we performed whole cell current measurements in
vector-only, WT PKD2  and R742X PKD2  clones. As
expected, HEK293 clones expressing wild-type PKD2 dis-
played an increase in the current amplitude of whole cell
inward and outward currents recorded either in normal
extracellular tyrode solution or symmetrical K+. Such
result excludes the possibility that an inactive PC-2 was
expressed in HEK293 cells. In addition, absence of pheno-
type could not be attributed to the mislocalization of the
expressed protein as determined by immunofluorescent
analysis.
In an attempt to clarify these contradictory results we uti-
lized a different cell line system. The NRK-52E cells are
"normal" rat tubular epithelial cells, thus we hypothe-
sized that this is a more appropriate system to study PC-2-
induced proliferation and STAT-1/p21/Cdk2 activation.
Nevertheless, similar results were obtained with the NRK-
52E cells (Figure 4). The disparity of our results compared
to previous studies is puzzling. Li et. al [17], observed cell
cycle arrest and Cdk2 inhibition in HEK293T cells after
expression of wild-type PC-2, and not in HEK293 cells
used in our study. HEK293T cell line is a derivative of
HEK293 that stably expresses the large T-antigen of SV40.
In these cells transfected plasmids that contain the SV40
origin are replicated to a copy number of 400–1000 plas-
mids/cell and therefore express the transgene at higher
levels. However, this is unlikely to be the reason for the
discrepancy given that high expression of wild-type and
mutated PC-2 was achieved in our HEK293 clones (Figure
1) and in NRK-52E cells (Figure 4) after transient transfec-
tion.
One of the unwanted side effects of cellular immortaliza-
tion might be the alteration of basal proliferation rate in
cells. This can be highly significant in proliferation stud-
ies. As a result we decided to switch to a primary cell cul-
ture system. We examined the ability of mutated PC-2 (1–
703) to activate the STAT-1/p21/Cdk2 pathway in pri-
mary renal epithelial cells isolated from PKD2(1–703)
transgenic rat [19].
Isolation of TECs from the transgenic animals was per-
formed using a sequential filtration method. Using this
method we avoided any potential activation of surface
receptors taking place during antibody-based isolation
techniques. Purified tubular epithelial cells were cultured
in low serum medium and on laminin-coated plates to
avoid differentiation. The epithelial character of the cells
was regularly evaluated by measuring epithelial (cad-
herin) and fibroblastic (vimentin) markers. TECs isolated
from different animals showed augmented PCNA levels, a
decrease of the G0/G1 phase cells and increase of the G2/
M phase cells. This was the first time in our hands that we
observed a higher proliferation activity in cells overex-
pressing a mutated PC-2. These results indicated that
indeed PC-2 can alter cellular proliferation in renal epi-
thelial cells, but it also suggests that such process is com-
plicated and possibly multifactorial and can not be easily
recapitulated in in vitro cell line systems [40]. In support
of this, a recent report focused on the dynamics of cyst for-
mation by utilizing an inducible Pkd1  mouse model,
demonstrated that proliferation was not appreciably
higher in cystic specimens than in aged matched controls.
Based on their results, the authors suggested that the rela-
tionship between cellular proliferation and cyst formation
may be indirect [41]. Similar data were obtained from
Zebrafish studies where it was shown that increased cell
number in cyctic phenotype is a secondary consequence
of tubule dilation rather than the leading cause of cyst for-
mation [42]. In our study, it appears that mutated PC-2-
induced proliferation in primary cells proceeds independ-
ently of the STAT-1/p21 pathway since there is no change
in the levels of p21 or on STAT-1 phosphorylation. Based
on these results it is clear that in the rat system we investi-
gated, PC-2-induced proliferation proceeds through an
alternative pathway other than STAT-1/p21.
Using gene expression profiling we were able to identify a
candidate that may mediate the PC2-induced prolifera-
tion in PKD2(1–703) rat. Among all the cell cycle related
genes, only two showed misregulation in TECs isolated
from diseased rats, cyclin-dependent kinase inhibitor 1CBMC Nephrology 2008, 9:10 http://www.biomedcentral.com/1471-2369/9/10
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(p57kip2) and Cdk2. The p57 kip2 belongs to the p21WAF/
Cip1 family. Studies have shown that p57 binds tightly to
the G1 and S phase kinases, cyclin E/Cdk2, cyclin D2/
Cdk4, cyclin A/Cdk2 and to a lesser extent to cyclin B/
Cdc2 and effectively inhibits their activity [43]. An impor-
tant difference between p57 and the other members of the
family, is that p57 is not regulated by p53 but by p73 [44-
46].
We observed a downregulation of p57 at both mRNA and
protein levels in mutant cells with the absence of any
change in p21 levels. This possibly signifies that PC-2
might alter cellular proliferation through p57/Cdk2 in
these cells. It is possible that expression of mutant PC-2
can result in p57 downregulation by augmenting Id2
nuclear import and subsequent inhibition of p57 tran-
scription [17]. This hypothesis is in agreement with exper-
iments in neural cells where it was shown that Id2 could
regulate cell cycle through p57 [47].
In addition to p57 downregulation, we observed an
increase in Cdk2 protein level. This is interesting since it
appears that Cdk2 activity might be augmented simulta-
neously in two different ways (downregulation of the
inhibitor and upregulation of the kinase). Whether Cdk2
increase is part of a positive feedback loop is still not
known. Nevertheless, this simultaneous alteration in p57
and Cdk2 levels might result in a rapid increase in Cdk2
activity and subsequently to higher proliferation rate. A
concern regarding our results might arise from the possi-
bility that the isolated TECs are not equally representative
of the various nephron segments in healthy and mutant
rats, a concern however that cannot easily be addressed
within the scope of this work. More specifically though,
we addressed the issue of over-representation of the TECs
from the proximal cysts by showing similar levels of a
proximal tubule marker, megalin expression in normal
and mutant TECs (Fig. 5A).
In conclusion, the level of p57 contribution in the PC-2-
induced proliferation in renal epithelial cells is still
unclear. Future experiments will focus on identifying the
pathways leading to p57 reduction and whether this
decrease is necessary for PC-2-induced proliferation in
renal tubular epithelial cells. We consider it of particular
significance that no matter how these experiments pan-
out, our study introduces a new pathway in ADPKD,
through which PC-2 might lead to Cdk2 activation and
increase in cellular proliferation, which is independent of
STAT-1/p21. Also, once again it should be emphasized
that biological systems are unpredictably complex and
may exert similar effects and end results through more
than one pathway. Finally a word of caution should be
expressed as regards the interpretation of experiments per-
formed on genetically grossly modified established cells
lines, which are far from representing the complexity of
whole organs or organisms.
Conclusion
We have shown that p57KIP2, a cyclin-dependent kinase
inhibitor is downregulated and cyclin-dependent kinase 2
(Cdk2) is upregulated in primary tubular epithelial cells
isolated from a PKD2 transgenic rat. In addition, primary
cells expressing mutant PKD2 exhibit increased prolifera-
tion compared to their normal counterparts. On the con-
trary, expression of mutant PKD2 in two kidney cell lines
failed to alter cellular proliferation and p57KIP2 protein
levels. Most importantly, although exogenous expression
of mutant PKD2  ablated current activity, compared to
wild-type, however in cell lines or primary TECs had no
effect on the STAT-1/p21/Cdk2 pathway. In conclusion
this report highlights the probable involvement of p57KIP2
on epithelial cell proliferation in ADPKD implicating a
new mechanism for mutant polycystin-2 induced prolifer-
ation.
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